Literature DB >> 10456661

Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: can they help in early detection?

N Campanella1, A Moraca, M Pergolini, W Daher, A Fianchini, A Sabbatini, A Brunelli, M Al-Refai.   

Abstract

The aim of this study was to assess the importance of paraneoplastic syndromes as an early sign of non-small cell lung cancer (NSCLC). A procedure for searching paraneoplastic syndromes, based on 40 years of reports in the literature, was established and the prevalence of paraneoplastic syndromes estimated in 68 patients with resectable NSCLC. Stages I and II were considered eligible for surgery straight away. Patients in Stage IIIA underwent surgery if partially or completely responsive to three courses of neo-adjuvant chemotherapy. Paraneoplastic syndromes were assessed and confirmed in nine patients (13%). Motor-sensory neuropathy, arthritis and arthralgias to the knees, periarthritis to the shoulder, hypertrophic osteopathy, clubbing, pruritus were observed. Only three patients with painful osteoarthropathies were diagnosed with NSCLC by tracing their paraneoplastic syndrome, whereas most of them (36/68) were diagnosed incidentally through a chest radiograph taken for tumour-unrelated symptoms. A careful research of paraneoplastic syndromes in high risk patients may guide the doctor to a resectable NSCLC diagnosis. Recent onset arthritis and arthralgias, which cannot be explained otherwise, should be considered to be early clues of lung cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10456661     DOI: 10.1007/bf02785846

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  9 in total

Review 1.  A new international staging system for lung cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1986-04       Impact factor: 9.410

2.  Relapse of Henoch-Schönlein disease associated with lung carcinoma.

Authors:  D M Mitchell; B I Hoffbrand
Journal:  J R Soc Med       Date:  1979-08       Impact factor: 5.344

3.  Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer.

Authors:  M H Gail; L Muenz; K R McIntire; B Radovich; G Braunstein; P R Brown; L Deftos; A Dnistrian; M Dunsmore; R Elashoff
Journal:  J Natl Cancer Inst       Date:  1988-03-16       Impact factor: 13.506

4.  Hypertrophic osteoarthropathy in staging skeletal scintigraphy for lung cancer.

Authors:  B Morgan; F Coakley; D B Finlay; I Belton
Journal:  Clin Radiol       Date:  1996-10       Impact factor: 2.350

5.  Carcinoma of bronchus presenting with Henoch-Schönlein purpura.

Authors: 
Journal:  Br Med J       Date:  1978-09-16

6.  Paraneoplastic syndromes: unusual manifestations of malignant disease.

Authors:  B I Shnider; A Manalo
Journal:  Dis Mon       Date:  1979-02       Impact factor: 3.800

Review 7.  Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature.

Authors:  J Sánchez-Guerrero; S Gutiérrez-Ureña; A Vidaller; E Reyes; A Iglesias; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1990-11       Impact factor: 4.666

8.  The World Health Organization. Histological typing of lung tumours.

Authors: 
Journal:  Neoplasma       Date:  1982       Impact factor: 2.575

9.  Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.

Authors:  V W Rusch; K S Albain; J J Crowley; T W Rice; V Lonchyna; R McKenna; R B Livingston; B R Griffin; J R Benfield
Journal:  J Thorac Cardiovasc Surg       Date:  1993-01       Impact factor: 5.209

  9 in total
  5 in total

1.  Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours.

Authors:  Rita Rugienė; Jolanta Dadonienė; Eduardas Aleknavičius; Renatas Tikuišis; Jörg Distler; Georg Schett; Paulius Venalis; Algirdas Venalis
Journal:  Clin Rheumatol       Date:  2011-01-12       Impact factor: 2.980

Review 2.  Chronic pruritus: a paraneoplastic sign.

Authors:  Gil Yosipovitch
Journal:  Dermatol Ther       Date:  2010 Nov-Dec       Impact factor: 2.851

3.  Adenocarcinoma of lung masquerading as systemic auto-immune disease.

Authors:  Kushal Naha; Sayali Thakare; G Vivek; Mukhyaprana Prabhu
Journal:  BMJ Case Rep       Date:  2012-06-14

Review 4.  Report of anti-CCP antibody positive paraneoplastic polyarthritis and review of the literature.

Authors:  Emily Larson; Delene Etwaru; Chokkalingam Siva; Kenneth Lawlor
Journal:  Rheumatol Int       Date:  2009-12-15       Impact factor: 2.631

Review 5.  Itch: Epidemiology, clinical presentation, and diagnostic workup.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Shawn G Kwatra
Journal:  J Am Acad Dermatol       Date:  2021-08-21       Impact factor: 11.527

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.